Featured Job
-
Job Removed or Not Found
Related Jobs
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.Education Qualifications (from an accredited college or
- Repligen (Waltham, MA)
- …Ability to work at a desk for extended periods, utilizing a computer and other standard office equipment. Visual and auditory ability to read detailed documents, analyze
- Eisai, Inc (Nutley, NJ)
- …The Associate Director supports the Eisai Global Oncology Business Unit for the Americas, EMEA, Japan, China, and Asia, by: Leading the development of Market / Commercial
- Eisai, Inc (Nutley, NJ)
- …The Executive Director, Regulatory Affairs will provide leadership and direction for the global regulatory aspects of Eisai's products under development and post approval
- Eisai, Inc (Nutley, NJ)
- …Associate Director, Global Alzheimer's Disease Project Management is responsible for facilitating the operational aspects of the lecanemab global launch plan, provide
- Repligen (Waltham, MA)
- OverviewThe Senior Director, Global Regulatory Affairs will report directly to the VP, Global Quality.This role will be accountable for the Regulatory oversight of all
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …CDx development : Provide critical strategic and tactical regulatory guidance for CDx/IVD development and CDx submission plan for each country/region, both before and
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …of the CoE as the organization grows and business needs evolve.Ensure the CoE's continuous operational execution and excellence by applying best practices in accordance
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.Education Qualifications (from an accredited college or
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …Senior clinical operational leader accountable for operational planning and execution of FIH, clin pharm patient studies, and Phases 1-3 clinical trials at the study and